Related Experiment Video
Updated: Aug 12, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
A kinetic study on murine myeloid leukaemia
British Journal of Cancer
|March 1, 1970
Summary
This study tracked murine myeloid leukemia growth using colony-forming units. Leukemia cells grew exponentially for 9 days before declining, showing sensitivity to chemotherapy drugs.
Area of Science:
- Hematology
- Cancer Research
- Pharmacology
Background:
- Murine myeloid leukemia serves as a model for human leukemia.
- Understanding leukemia kinetics is crucial for treatment strategies.
Purpose of the Study:
- To investigate the kinetic behavior of murine myeloid leukemia.
- To assess the sensitivity of myeloid leukemia to specific chemotherapeutic agents.
Main Methods:
- Kinetic study of myeloid leukaemia colony-forming units (MLCFU) in bone marrow, spleen, and liver.
- Analysis of MLCFU growth curves and survival curves after drug treatment.
Main Results:
- MLCFU increased exponentially from day 1 to day 9, with a lag phase of 12-24 hours.
- A decline in MLCFU was observed after day 10 in the studied organs.
- Myeloid leukemia demonstrated sensitivity to cyclophosphamide and chlorambucil.
Conclusions:
- The study elucidates the growth kinetics of murine myeloid leukemia.
- Chemotherapeutic agents cyclophosphamide and chlorambucil show efficacy.
- A mixed-type entity within myeloid leukemia colonies was identified.
